Advertisement

Orthopedic medical device maker Wright Medical's company-wide overhaul is on or ahead of schedule in most areas, and the company is looking forward to closing the $390 million buyout of BioMimetic Therapeutics.

Wright Medical Group logo

Orthopedic giant Wright Medical (NSDQ:WMGI) is back on track, CEO Robert Palmisano told an audience at the J.P. Morgan Healthcare conference in San Francisco yesterday.

Following a rough patch, which included a deferred prosecution agreement over allegations that the company engaged in illegal kickbacks for hip and knee devices, Wright is looking to turn things around.

Advertisement
Advertisement